NHS England proposes phased rollout for Eli Lilly's star obesity drug
While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, Kwikpen, was endorsed in January by the Medicines & Healthcare products Regulatory Agency (MHRA). The product was cleared for both type 2 diabetes and obesity patients.